Nicolin 2, pseudogene (NICN2P)

Nicolin 2, pseudogene (NICN2P), is classified as a **pseudogene**, meaning it is a segment of DNA that resembles a gene but generally lacks the capacity to encode a functional protein due to disabling mutations or disruptions (such as frameshifts, premature stop codons, or loss of regulatory elements)[1][3]. Pseudogenes are typically considered "non-functional" at the protein level, but in some cases, they may play regulatory roles as non-coding RNAs, influencing gene expression by acting as molecular sponges for microRNAs or competing endogenous RNAs[1][3]. Currently, there is no evidence in the scientific literature that NICN2P has any such regulatory function or involvement in human disease. It is not considered a therapeutic target, receptor, enzyme, transporter, or any other class of actionable molecular target. **Notes on correctness and naming**: - There is no evidence that **NICN2P (Nicolin 2, pseudogene)** encodes a functional protein, nor is it referenced as a target in drug discovery literature. - It is classified as a **pseudogene**—a non-coding genetic element—which by definition is not a canonical therapeutic target[1][3]. - No common aliases or abbreviations are in use, and there is no evidence of clinical relevance. If you are seeking information on a protein-coding gene or target related to "nicolin" or "nicn2" (potential parent gene), ensure the query refers to the correct, protein-coding gene rather than its pseudogene. If you need information on the protein-coding "nicolin 2" gene, let me know so I can clarify the appropriate target. **Summary**: NICN2P is a **pseudogene**, not a therapeutic target, with no established biological, clinical, or pharmacological information[1][3]. If your intent was to find information about a functional gene or receptor, you may wish to review the gene symbol for accuracy.